Population
598 heparinized plasma samples received for routine clinical analysis
Comparison
Measurement of cardiac troponin I using the… vs Measurement of cTnI using the Beckman-Coulter…
Authors
Loading...
Clinicians should consider hemolysis interference with the ECi cTnI assay at low cutoffs; leaves open optimal platform selection pending further validation.
Hemolysis can cause false-positive cardiac troponin I results in the Vitros ECi assay, highlighting the need to consider hemolysis interference when selecting assays and clinical cutoffs.
Robert C. Hawkins (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: